Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_assertion type Assertion NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_head.
- NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_assertion description "[Our findings offer a preclinical validation of the HIF-1/PDK3 bioenergetic pathway as a new target for therapeutic intervention in metastatic melanoma, opening the door to innovative combinations that might eradicate this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_provenance.
- NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_assertion evidence source_evidence_literature NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_provenance.
- NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_assertion SIO_000772 22865452 NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_provenance.
- NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_assertion wasDerivedFrom befree-20140225 NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_provenance.
- NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_assertion wasGeneratedBy ECO_0000203 NP531516.RAiiCSuRNHV2-X52gOn2MjiyhmLLdxcV5GyWkFEMXAbS0130_provenance.